Study to Evaluate the Cardiac Safety of TAS-102 in Patients With Advanced Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Advanced Solid Tumors (Excluding Breast Cancer)
Interventions: DRUG: TAS-102|DRUG: Placebo
Sponsor: Taiho Oncology, Inc.